The collaboration with Samsung will leverage GreenLight's existing manufacturing process, and technology transfer to Samsung will begin immediately, according to both firms.
GreenLight Biosciences is a biotechnology company that was founded in 2008; it is dedicated to making RNA products affordable and accessible. In August 2021, GreenLight announced plans to become publicly listed through a business combination with Environmental Impact Acquisition Corp.
Samsung Biologics is a contract manufacturing organization that provides integrated end-to-end contract development and manufacturing services.
Copyright © 2021 scienceboard.net